Literature DB >> 7841033

The role of p53 inactivation in human cervical cell carcinoma development.

K Miwa1, S Miyamoto, H Kato, T Imamura, M Nishida, Y Yoshikawa, Y Nagata, N Wake.   

Abstract

We investigated the association between human papillomavirus (HPV) infection and p53 gene mutation in 47 primary uterine cervical cancers. HPV DNA sequences were present in 43 cancers (91.5%), and one of these cancers contained a p53 gene mutation. In addition, one of the remaining four HPV-negative cancers also contained a p53 gene mutation. As a result, p53 inactivation corresponded to the development of 44 of the primary uterine cervical cancers studied (93.6%). We obtained both primary and recurrent tumours from four cases. In two of these cases, the HPV genomes that were present in an episomal state in the primary tumours were observed to have disappeared in the recurrent tumours. One of these recurrent tumours also contained a p53 gene mutation, which suggested the possibility that p53 inactivation was required in order to maintain the aggressive behaviour in this cancer either by an HPV infection or by a p53 gene mutation. No MDM2 gene amplification was observed in the tumours that carried neither HPV DNAs nor p53 gene mutations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7841033      PMCID: PMC2033612          DOI: 10.1038/bjc.1995.47

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Papillomaviruses in human cancer.

Authors:  H zur Hausen
Journal:  Appl Pathol       Date:  1987

2.  Purification of DNA from formaldehyde fixed and paraffin embedded human tissue.

Authors:  S E Goelz; S R Hamilton; B Vogelstein
Journal:  Biochem Biophys Res Commun       Date:  1985-07-16       Impact factor: 3.575

3.  Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.

Authors:  C A Finlay; P W Hinds; T H Tan; D Eliyahu; M Oren; A J Levine
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

Review 4.  Human papillomaviruses: are we ready to type?

Authors:  A Roman; K H Fife
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

5.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

Authors:  N Dyson; P M Howley; K Münger; E Harlow
Journal:  Science       Date:  1989-02-17       Impact factor: 47.728

6.  Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases?

Authors:  P G Fuchs; F Girardi; H Pfister
Journal:  Int J Cancer       Date:  1989-01-15       Impact factor: 7.396

7.  Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells.

Authors:  M A Bedell; K H Jones; S R Grossman; L A Laimins
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

8.  Mutations of p53 and human papillomavirus infection in cervical carcinoma.

Authors:  R L Paquette; Y Y Lee; S P Wilczynski; A Karmakar; M Kizaki; C W Miller; H P Koeffler
Journal:  Cancer       Date:  1993-08-15       Impact factor: 6.860

9.  The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells.

Authors:  T M Chen; C A Chen; C Y Hsieh; D Y Chang; Y H Chen; V Defendi
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

10.  Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53.

Authors:  T Soussi; C Caron de Fromentel; M Méchali; P May; M Kress
Journal:  Oncogene       Date:  1987-03       Impact factor: 9.867

View more
  11 in total

1.  p53 expression in carcinoma of the cervix.

Authors:  C R Hunt; R J Hale; C H Buckley; J Hunt
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

2.  Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.

Authors:  H Y Ngan; S W Tsao; S S Liu; M Stanley
Journal:  Genitourin Med       Date:  1997-02

3.  Post-transcriptional induction of p21cip1 protein in condylomata and dysplasias is inversely related to human papillomavirus activities.

Authors:  D C Schmidt-Grimminger; X Wu; Y Jian; T R Broker; L T Chow
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

4.  Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection.

Authors:  G Troncone; J C Martinez; L Palombini; G De Rosa; C Mugica; J A Rodriguez; P Zeppa; D Di Vizio; A Lucariello; M A Piris
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

5.  Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis.

Authors:  Eun-Woo Lee; Min-Sik Lee; Suzanne Camus; Jaewang Ghim; Mi-Ran Yang; Wonkyung Oh; Nam-Chul Ha; David P Lane; Jaewhan Song
Journal:  EMBO J       Date:  2009-06-18       Impact factor: 11.598

Review 6.  Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer.

Authors:  F J Crowley; R E O'Cearbhaill; D C Collins
Journal:  Cancer Treat Rev       Date:  2021-05-23       Impact factor: 13.608

7.  A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix.

Authors:  S Nakagawa; H Yoshikawa; M Kimura; K Kawana; K Matsumoto; T Onda; N Kino; M Yamada; T Yasugi; Y Taketani
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

8.  Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.

Authors:  S Nakagawa; H Yoshikawa; H Jimbo; T Onda; T Yasugi; K Matsumoto; N Kino; K Kawana; T Kozuka; K Nakagawa; M Aoki; Y Taketani
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

9.  Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.

Authors:  A Helland; F Karlsen; E U Due; R Holm; G Kristensen; A l Børresen-Dale
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

10.  Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer.

Authors:  Yoo-Young Lee; Young-Jae Cho; Sung-Won Shin; Changhoon Choi; Ji-Yoon Ryu; Hye-Kyung Jeon; Jung-Joo Choi; Jae Ryoung Hwang; Chel Hun Choi; Tae-Joong Kim; Byoung- Gie Kim; Duk-Soo Bae; Won Park; Jeong-Won Lee
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.